Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 2:54 PM
Ignite Modification Date:
2025-12-24 @ 2:54 PM
NCT ID:
NCT02669459
Eligibility Criteria:
Inclusion Criteria:
* Histologically proven CIN 2 or CIN 3, without invasion after previous surgical treatment at least 6 months before diagnosis.
* Histologically proven recurrent CIN 1 after previous surgical treatment at least 6 months before diagnosis. Persistent CIN 1 is defined as CIN 1 at least persistent for 6 months and proven with histology.
* The patient is willing to use a medically acceptable method of contraception throughout the study
* Women older than 18 years of age.
Exclusion Criteria:
* Pregnancy or lactation
* (Micro-)invasive carcinoma
* Past history of cervical cancer
* Hypersensitivity of any components of the formulation
* History of psoriasis or other inflammatory dermatosis of the vulva
* Immunodeficiency or treatment with immunosuppressive medication
* Insufficient understanding of the Dutch or English language
Healthy Volunteers:
False
Sex:
FEMALE
Minimum Age:
18 Years
Study:
NCT02669459
Study Brief:
Protocol Section:
NCT02669459